Jessie Becker, co-founder and CEO of InPress Technologies, and Surbhi Sarna, founder and CEO of nVision Medical, both made the Forbes “30 Under 30” list.
Our companies-in-residence make incredible strides in advancing medical technology on a daily basis and it is highly rewarding when their hard efforts are recognized by both the medical and business communities.
Recently, Jessie Becker co-founder and CEO of InPress Technologies, made the Forbes annual “30 Under 30” list, which identifies the best and brightest innovators. Jessie is the second honoree from the Fogarty Institute to receive the award — Surbhi Sarna, founder and CEO of nVision Medical, made the list in 2014. Both women were among a handpicked group of entrepreneurs recognized for shaping the future of healthcare.
InPress is developing a simple device that is intended to quickly and effectively stop postpartum hemorrhage (PPH), which is the leading cause of maternal death globally, taking the life of one woman every four minutes. Early results of the company’s clinical trial in Jakarta, Indonesia, have been 100 percent successful. The company has already raised $1.5 million in seed money.